Su Chi Lim

6.6k total citations · 1 hit paper
146 papers, 4.7k citations indexed

About

Su Chi Lim is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Nephrology. According to data from OpenAlex, Su Chi Lim has authored 146 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Endocrinology, Diabetes and Metabolism, 48 papers in Cardiology and Cardiovascular Medicine and 39 papers in Nephrology. Recurrent topics in Su Chi Lim's work include Chronic Kidney Disease and Diabetes (34 papers), Diabetes Treatment and Management (27 papers) and Cardiovascular Health and Disease Prevention (26 papers). Su Chi Lim is often cited by papers focused on Chronic Kidney Disease and Diabetes (34 papers), Diabetes Treatment and Management (27 papers) and Cardiovascular Health and Disease Prevention (26 papers). Su Chi Lim collaborates with scholars based in Singapore, United States and Australia. Su Chi Lim's co-authors include Tavintharan Subramaniam, Chee Fang Sum, Jianjun Liu, Sylvia Liu, Michael Wong, A. Enrique Caballero, Frank W. LoGerfo, Kandiah Jeyaseelan, Dwi Setyowati Karolina and Arunmozhiarasi Armugam and has published in prestigious journals such as Nature Communications, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Su Chi Lim

140 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes.

1999 524 citations Su Chi Lim et al. Diabetes profile →

Peers

Countries citing papers authored by Su Chi Lim

Since Specialization

Citations

This map shows the geographic impact of Su Chi Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su Chi Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su Chi Lim more than expected).

Fields of papers citing papers by Su Chi Lim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Su Chi Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su Chi Lim. The network helps show where Su Chi Lim may publish in the future.

Co-authorship network of co-authors of Su Chi Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Su Chi Lim. A scholar is included among the top collaborators of Su Chi Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Su Chi Lim. Su Chi Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Association of Plasma Angiogenin With Risk of Incident End-Stage Kidney Disease in Individuals With Type 2 Diabetes 2025 ·Diabetes ·Resham L Gurung, Jianjun Liu, Sylvia Liu, (unknown), Huili Zheng, Clara C. Chan, Keven Ang, Su Chi Lim	0
2	Reduced skeletal muscle mass to visceral fat area ratio is independently associated with reduced cognitive function in type 2 diabetes mellitus 2024 ·Journal of Diabetes and its Complications ·Serena Low, Tze Pin Ng, (unknown), Angela Moh, (unknown), Keven Ang, Philip Yap, Chin Yee Cheong, Wern Ee Tang, (unknown), Tavintharan Subramaniam, Chee Fang Sum, Su Chi Lim	4
3	Acute kidney injury predicts the risk of adverse cardio renal events and all cause death in southeast Asian people with type 2 diabetes 2024 ·Scientific Reports ·(unknown), (unknown), (unknown), (unknown), Huili Zheng, Clara C. Chan, Yi Ming Shao, Resham L Gurung, Keven Ang, Su Chi Lim	1
4	Association between lower phase angle and chronic kidney disease progression in type 2 diabetes patients 2023 ·Annals of the Academy of Medicine Singapore ·Serena Low, Sharon Li Ting Pek, Angela Moh, (unknown), Keven Ang, Wern Ee Tang, (unknown), Tavintharan Subramaniam, Chee Fang Sum, Su Chi Lim	2
5	HNF1A binds and regulates the expression of SLC51B to facilitate the uptake of estrone sulfate in human renal proximal tubule epithelial cells 2023 ·Cell Death and Disease ·(unknown), (unknown), (unknown), Hyungwon Choi, Su Chi Lim, E Shyong Tai, Adrian Kee Keong Teo	5
6	Deep learning algorithms to detect diabetic kidney disease from retinal photographs in multiethnic populations with diabetes 2023 ·Journal of the American Medical Informatics Association ·Bjorn Kaijun Betzler, (unknown), (unknown), Cynthia Ciwei Lim, Jinyi Ho, Haslina Hamzah, Ngiap Chuan Tan, Gerald Liew, Gareth J. McKay, Ruth Hogg, Ian Young, Ching‐Yu Cheng, Su Chi Lim, Aaron Lee, Tien Yin Wong, Mong Li Lee, Wynne Hsu, Gavin Siew Wei Tan, Charumathi Sabanayagam	14
7	12-OR: Urine Lactate Is a Disease Biomarker for Diabetic Kidney Disease 2023 ·Diabetes ·(unknown), Manjula Darshi, Vikas S. Sridhar, Viktor R. Drel, Jana Tůmová, (unknown), Jiexun Wang, (unknown), (unknown), Loki Natarajan, Su Chi Lim, Sushrut S. Waikar, (unknown), Jiang He, Volker Vallon, Stein Hallan, (unknown), Kumar Sharma, (unknown)	2
8	Association between self-care and chronic kidney disease in patients with type 2 diabetes mellitus 2023 ·Annals of the Academy of Medicine Singapore ·(unknown), Serena Low, Allen Yan Lun Liu, Yi Ming Shao, Tavintharan Subramaniam, Chee Fang Sum, Su Chi Lim	1
9	Plasma Tryptophan-Kynurenine Pathway Metabolites and Risk for Progression to End-Stage Kidney Disease in Patients With Type 2 Diabetes 2023 ·Diabetes Care ·Jianjun Liu, Jianhong Ching, (unknown), Sylvia Liu, Resham L Gurung, (unknown), (unknown), Huili Zheng, (unknown), Keven Ang, Yi Ming Shao, Jean‐Paul Kovalik, Tavintharan Subramaniam, Chee Fang Sum, Kumar Sharma, Bryan Kestenbaum, Su Chi Lim	21
10	MODY5 Hepatocyte Nuclear Factor 1ß (HNF1ß)-Associated Nephropathy: experience from a regional monogenic diabetes referral centre in Singapore 2022 ·Journal of Investigative Medicine High Impact Case Reports ·(unknown), Su Fen Ang, Ester Yeoh, (unknown), Wann Jia Loh, (unknown), M Eng, Allen Yan Lun Liu, (unknown), (unknown), Tavintharan Subramaniam, Chee Fang Sum, Su Chi Lim	3
11	Higher extracellular water to total body water ratio was associated with chronic kidney disease progression in type 2 diabetes 2021 ·Journal of Diabetes and its Complications ·Serena Low, Sharon Li Ting Pek, Allen Yan Lun Liu, Angela Moh, Keven Ang, Wern Ee Tang, (unknown), Tavintharan Subramaniam, Chee Fang Sum, Chin Leong Lim, Yusuf Ali, Su Chi Lim	21
12	Clinical experience from a regional monogenic diabetes referral centre in Singapore 2020 ·Diabetes Research and Clinical Practice ·Su Fen Ang, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Chee Fang Sum, Su Chi Lim	8
13	The prevalence of sarcopenic obesity and its association with cognitive performance in type 2 diabetes in Singapore 2019 ·Clinical Nutrition ·Serena Low, (unknown), Tze Pin Ng, Su Fen Ang, Angela Moh, Jiexun Wang, Keven Ang, Tavintharan Subramaniam, Chee Fang Sum, Su Chi Lim	46
14	HbA1c variability in type 2 diabetes is associated with the occurrence of new-onset albuminuria within three years 2017 ·Diabetes Research and Clinical Practice ·(unknown), (unknown), (unknown), Su Chi Lim, Chun Wei Yap, Alexandre Chan, (unknown)	16
15	Development and validation of a predictive model for Chronic Kidney Disease progression in Type 2 Diabetes Mellitus based on a 13-year study in Singapore 2016 ·Diabetes Research and Clinical Practice ·Serena Low, Su Chi Lim, Xiao Zhang, Shiyi Zhou, Lee Ying Yeoh, Allen Yan Lun Liu, Tavintharan Subramaniam, Chee Fang Sum	41
16	Association of the anti-angiogenic factor secreted protein and rich in cysteine (SPARC) with vascular complications among Chinese type 2 diabetic patients in Singapore 2016 ·Journal of Diabetes and its Complications ·Mei Chung Moh, Chee Fang Sum, Tavintharan Subramaniam, Sharon Li Ting Pek, Lee Ying Yeoh, (unknown), (unknown), Wern Ee Tang, Su Chi Lim	2
17	Carotid Intima-Media Thickness Is Associated With the Progression of Cognitive Impairment in Older Adults 2015 ·Journal of Vascular Surgery ·Joonho Moon, Su Chi Lim, Jeong‐Won Han	1
18	The Relationship of Retinopathy Signs and Chronic Kidney Disease in Persons without Diabetes: the Singapore Epidemiology of Eye Disease (SEED) Study 2013 ·Investigative Ophthalmology & Visual Science ·Merwyn Chew, Charumathi Sabanayagam, Wan Ting Tay, Su Chi Lim, E Shyong Tai, Tien Yin Wong	0
19	Ethnic disparities in prevalence and impact of risk factors of chronic kidney disease 2010 ·Nephrology Dialysis Transplantation ·Charumathi Sabanayagam, Su Chi Lim, Tien Yin Wong, Jimmy Lee, A. Shankar, E Shyong Tai	56
20	Oxidative burden in prediabetic and diabetic individuals: evidence from plasma coenzyme Q₁₀ 2006 ·Diabetic Medicine ·Su Chi Lim, (unknown), (unknown), T. Subramaniam, Chee Fang Sum, (unknown), (unknown), Choon Nam Ong	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact